Safety and Efficacy Study in Subjects With Seborrheic Dermatitis

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if two test products are safe and effective in the treatment of seborrheic dermatitis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medicis Global Service Corporation

Criteria

Inclusion Criteria:

• Investigator assessment of seborrheic dermatitis.

• Additional criteria as identified in the protocol.

Exclusion Criteria:

• History of or ongoing psoriasis of the scalp.

• History of or ongoing atopic dermatitis of the scalp.

• Additional criteria as identified in the protocol.